The Impact of Credit-based Insurance Scoring on the Availability and Affordability of Insurance

The Impact of Credit-based Insurance Scoring on the Availability and Affordability of Insurance
Author :
Publisher :
Total Pages : 364
Release :
ISBN-10 : PSU:000065506158
ISBN-13 :
Rating : 4/5 ( Downloads)

Book Synopsis The Impact of Credit-based Insurance Scoring on the Availability and Affordability of Insurance by : United States. Congress. House. Committee on Financial Services. Subcommittee on Oversight and Investigations

Download or read book The Impact of Credit-based Insurance Scoring on the Availability and Affordability of Insurance written by United States. Congress. House. Committee on Financial Services. Subcommittee on Oversight and Investigations and published by . This book was released on 2008 with total page 364 pages. Available in PDF, EPUB and Kindle. Book excerpt:


The Impact of Credit-based Insurance Scoring on the Availability and Affordability of Insurance Related Books

The Impact of Credit-based Insurance Scoring on the Availability and Affordability of Insurance
Language: en
Pages: 364
Authors: United States. Congress. House. Committee on Financial Services. Subcommittee on Oversight and Investigations
Categories: Business & Economics
Type: BOOK - Published: 2008 - Publisher:

GET EBOOK

Credit-based Insurance Scores
Language: en
Pages: 256
Authors: United States. Congress. House. Committee on Financial Services. Subcommittee on Oversight and Investigations
Categories: Credit ratings
Type: BOOK - Published: 2008 - Publisher:

GET EBOOK

Report on the Activity of the Committee on Financial Services for the One Hundred Tenth Congress
Language: en
Pages: 204
Authors: United States. Congress. House. Committee on Financial Services
Categories:
Type: BOOK - Published: 2009 - Publisher:

GET EBOOK

Generic Drug Entry Prior to Patent Expiration
Language: en
Pages:
Authors: United States. Federal Trade Commission
Categories: Drugs
Type: BOOK - Published: 2002 - Publisher:

GET EBOOK

In April 2001, the Commission began an industry-wide study focused on certain aspects of generic drug competition under the Hatch-Waxman Amendments. The Amendme